NEWS

Two Years On: Stem Cell Therapy Brings Sustained Vision Improvement Thanks to Alginate-Based Delivery

Two Years On: Stem Cell Therapy Brings Sustaine...

At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone from our partners at the L V Prasad Eye Institute (LVPEI)...

Two Years On: Stem Cell Therapy Brings Sustaine...

At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone from our partners at the L V Prasad Eye Institute (LVPEI)...

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Atelerix signs exclusive agreement with MineBio...

Atelerix partners with MineBio to bring cryo-free cell preservation to China, expanding global access to its breakthrough hydrogel technology.The exclusive agreement enables efficient ambient-temperature transport of sensitive biomaterials, supporting growth...

Atelerix signs exclusive agreement with MineBio...

Atelerix partners with MineBio to bring cryo-free cell preservation to China, expanding global access to its breakthrough hydrogel technology.The exclusive agreement enables efficient ambient-temperature transport of sensitive biomaterials, supporting growth...

We’re Finalists (Twice!) at the Medilink Healthcare Business Awards 2025

We’re Finalists (Twice!) at the Medilink Health...

Atelerix has been shortlisted for both the Start Up and Sustainability categories at the Medilink Healthcare Business Awards 2025, recognising its rapid growth and commitment to greener biotech solutions. The...

We’re Finalists (Twice!) at the Medilink Health...

Atelerix has been shortlisted for both the Start Up and Sustainability categories at the Medilink Healthcare Business Awards 2025, recognising its rapid growth and commitment to greener biotech solutions. The...

Atelerix launch new Bloodready product

Atelerix Launches BloodReady™: A Breakthrough i...

Atelerix, the pioneering biotech company revolutionising cell preservation, has unveiled BloodReady™, a first-of-its-kind solution that extends the shelf life of fresh whole blood for up to three days at refrigerated...

Atelerix Launches BloodReady™: A Breakthrough i...

Atelerix, the pioneering biotech company revolutionising cell preservation, has unveiled BloodReady™, a first-of-its-kind solution that extends the shelf life of fresh whole blood for up to three days at refrigerated...

Atelerix raises £750k to revolutionise biological transport

Atelerix raises £750k to revolutionise biologic...

Atelerix has raised £750k to accelerate the global adoption of its innovative hypothermic preservation technology, which enables biosamples like cells and tissues to be transported at room temperature with over...

Atelerix raises £750k to revolutionise biologic...

Atelerix has raised £750k to accelerate the global adoption of its innovative hypothermic preservation technology, which enables biosamples like cells and tissues to be transported at room temperature with over...

Preserving Cell Functionality: Cryopreservation vs. Hypothermic Hydrogel Technology

Preserving Cell Functionality: Cryopreservation...

Atelerix's hypothermic hydrogel technology presents a greener alternative to traditional cryopreservation methods for cell storage and transport. While cryopreservation, which involves ultra-low temperature storage, can significantly reduce cell viability and...

Preserving Cell Functionality: Cryopreservation...

Atelerix's hypothermic hydrogel technology presents a greener alternative to traditional cryopreservation methods for cell storage and transport. While cryopreservation, which involves ultra-low temperature storage, can significantly reduce cell viability and...